Acute 20ischemic 20stroke
A 20ancd

Anaconda BioMed

A team of experts in medical devices able to seize the market opportunity currently existing in the stroke treatment and bring its technology to the patients.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Sant Cugat del Vallès, Spain
  • Currency EUR
  • Founded April 2015
  • Employees 5
  • Website anaconda.bio

Company Summary

El ictus es la primera causa de discapacidad en el mundo. Después de los buenos resultados de varios ensayos clínicos, las guías médicas recomiendan ahora combinar trombolíticos IV con trombectomía endovascular.
Actualmente hay dos posibles soluciones:
• El uso de un catéter de acceso distal para aspirar el trombo. El principal inconveniente de esta técnica es que el flujo no se detiene y el tamaño del orificio es más pequeño que el trombo.
• Stent retrievers, se utilizan normalmente con un balón carótideo que detiene el flujo. Pero los trombos necesitan ser arrastrados una larga distancia y la aspiración no es lo suficientemente eficiente.
El inconveniente de la trombectomía es la embolización distal debido a las partículas que se liberan durante estos procedimientos largos y complejos.
ANCD brain se compone de un stent recubierto que actúa como un embudo para evitar que las partículas se liberen y resolver así la causa principal de la embolización distal.

Team

  • 95978d22 00ba 4774 834a e4b5746610f1
    co-founder & CEO

    Dr. Arad has 13 years of experience in the biomedical field. He has developed biomaterials for the medical devices industry like polymers for controlled drug elution.
    Dr. Arad has developed drug eluting stents and thrombus aspiration catheters among other medical devices for interventional cardiology applications.

  • F33e5115 d546 464d b936 a783b1148c99
    Chief Financial Officer

    Mr. Alain Garcinuño has 12 years experience in the financial capital markets with access to national and international business angels and early stage VC firms.

  • Default avatar
    Marc Ribó
    co-founder & Chief Scientific Officer

    Dr. Ribó is an experienced Interventional Neurologist at Hospital Vall d’Hebron.
    Dr. Ribó has published over 150 Research papers in some of the most prestigious journals, including the New England Journal of Medicine, and has received several international Awards in recognition for his work. He has also consulted for several medical devices companies.

  • Default avatar
    Uri Fligil
    Business Development Director

    Mr. Uri Fligil has 15 years experience distributing medical devices working both for international leading companies and medtech start-ups.

Advisors

Previous Investors

  • Default avatar
    Carol Roig Balagué
    inversora
    Unconfirmed
    3627d9a1 542e 4807 9a71 56394c474dea
    investor
    Dsc 0320
    Investor
  • Default avatar
    Yoni Daniel
    Investor
    Unconfirmed
    Default avatar
    Erwin Hefti
    Investor
    Unconfirmed
    Default avatar
    Amitai Katz
    Investor
    Unconfirmed
  • Default avatar
    Uri Fligil
    Investor
    Unconfirmed
    Default avatar
    Marian Szeinberg
    Investor
    Unconfirmed
    Default avatar
    Carlos Carrera
    Investor
    Unconfirmed
  • Default avatar
    Sergi Roig
    Investor
    Unconfirmed
    Default avatar
    Marta Balagué
    Investor
    Unconfirmed